No, 401(k) Funds Do Not Cost 2% Per Year Beware the claims of investment personalities. John Rekenthaler Mar 21, 2024
The Magnificent Seven: Fortune or Folly? An impartial look at these stocks’ long-term prospects. John Rekenthaler Mar 11, 2024
The Optimists Were Right About FANG Stocks And the growth-stock skeptics were very, very wrong. John Rekenthaler Mar 7, 2024
Should Target-Date Funds Allot More to Equities? What a “reverse glide path” would look like. John Rekenthaler Mar 4, 2024
When Bonds Beat Stocks: Emerging Markets How emerging-markets equities turned gold into lead. John Rekenthaler Feb 29, 2024
More Than Ever, Stock Investors Are Thinking Like Owners How equity shareholders have gained their voices—and will continue to do so. John Rekenthaler Feb 26, 2024
The Two Great Myths of Social Security Reform How the debate about Social Security misses the mark. John Rekenthaler Feb 7, 2024
Should ESG Investing Be Criminalized? The question, regrettably, is not a joke. John Rekenthaler Jan 31, 2024
Covered-Call Funds: A Mystery Wrapped in an Enigma These funds can perform well, but it’s hard to predict under what conditions. John Rekenthaler Jan 25, 2024
Covered-Call Stock Funds Like JEPI Are Popular. Should They Be? High distributions from these funds don’t tell the whole story. John Rekenthaler Jan 22, 2024
Skipping Your Morning Coffee Won’t Make You a Millionaire As fables go, however, this one is relatively useful. John Rekenthaler Jan 12, 2024
Stocks Have Not Always Beaten Bonds. Should You Care? How relevant are the experiences of other countries and other eras? John Rekenthaler Jan 11, 2024
Do Stocks Really Make Sense for the Long Run? New research threatens the conventional wisdom. John Rekenthaler Jan 8, 2024